Investor Relations

Investor Relations


The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has approximately 8,000 employees with products sold in over 100 countries. For more information, please visit

View all »Upcoming Events & Presentations

Sep 4, 2014 at 5:00 PM ET
The Cooper Companies Third Quarter 2014 Earnings

Sep 11, 2014 at 8:00 AM ET
The Cooper Companies 2014 Analyst Meeting

View all »   RSSRecent Press Releases

Aug 6, 2014
The Cooper Companies Completes Acquisition of Sauflon Pharmaceuticals and Announces $700 Million 3-Year Term Loan

Aug 4, 2014
The Cooper Companies Announces Release Date for Third Quarter 2014